Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

Table 2.4.b. Serum alpha-carotene: Mexican Americans

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S.population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean(95% conf. interval)

Selected percentiles (95% conf. interval)

Samplesize

10th

50th

90th

Males and Females

Total, 3 years and older

2.72

(2.39-3.10)

1.00

(.900-1.10)

2.50

(2.30-2.80)

7.40

(6.30-8.90)

2116

3–5 years

2.56

(2.12-3.08)

1.00

(.800-1.50)

2.20

(2.10-2.50)

6.40

(4.50-9.00)

126

6–11 years

2.43

(2.12-2.79)

.900

(.800-1.10)

2.20

(2.00-2.70)

5.40

(4.70-6.70)

290

12–19 years

1.90

(1.71-2.11)

.700

(<LOD-.800)

1.70

(1.50-2.10)

5.30

(3.90-6.40)

696

20–39 years

2.92

(2.48-3.43)

1.00

(.800-1.30)

2.80

(2.50-3.40)

8.00

(6.60-9.10)

460

40–59 years

3.39

(2.71-4.24)

1.10

(.900-1.40)

3.30

(2.60-4.10)

8.70

(7.20-14.3)

289

60 years and older

3.04

(2.35-3.94)

.900

(<LOD-1.30)

2.90

(2.30-4.00)

8.90

(6.20-13.7)

255

Males

Total, 3 years and older

2.46

(2.13-2.83)

.800

(.700-1.00)

2.44

(2.20-2.70)

6.60

(5.30-8.00)

1019

3–5 years

2.37

(1.70-3.32)

.800†

(<LOD-1.50)

2.20

(1.70-2.80)

5.90†

(2.90-12.1)

62

6–11 years

2.39

(1.89-3.03)

.800

(.700-1.00)

2.20

(1.70-2.90)

5.50

(3.90-8.40)

140

12–19 years

1.69

(1.48-1.92)

.700

(<LOD-.800)

1.50

(1.30-1.90)

4.20

(3.30-6.20)

330

20–39 years

2.51

(2.06-3.06)

.800

(<LOD-1.10)

2.60

(2.10-3.10)

6.70

(5.20-7.90)

213

40–59 years

3.33

(2.61-4.23)

1.20

(.800-1.70)

3.20

(2.50-4.10)

8.10

(5.90-13.2)

149

60 years and older

2.49

(1.83-3.38)

.700

(<LOD-1.10)

2.60

(1.90-3.00)

7.00

(5.50-9.10)

125

Females

Total, 3 years and older

3.04

(2.66-3.48)

1.00

(.900-1.20)

2.80

(2.50-3.30)

8.50

(7.10-10.8)

1097

3–5 years

2.75

(2.28-3.32)

1.20†

(<LOD-1.60)

2.40

(2.00-3.10)

6.00†

(4.20-9.00)

64

6–11 years

2.48

(2.16-2.85)

1.20

(.900-1.50)

2.30

(1.90-3.00)

5.00

(4.00-6.00)

150

12–19 years

2.16

(1.92-2.43)

.800

(.700-.900)

2.00

(1.60-2.50)

5.80

(4.40-7.30)

366

20–39 years

3.45

(2.87-4.15)

1.20

(.900-1.40)

3.20

(2.60-4.30)

9.10

(8.00-12.7)

247

40–59 years

3.46

(2.66-4.49)

.900

(.700-1.40)

3.30

(2.40-4.80)

10.8

(8.00-14.8)

140

60 years and older

3.58

(2.63-4.86)

1.30

(.900-1.80)

3.60

(2.40-4.80)

11.5

(6.00-15.2)

130

< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.

Table 2.4.c. Serum alpha-carotene: Non-Hispanic blacks

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S.population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean(95% conf. interval)

Selected percentiles (95% conf. interval)

Samplesize

10th

50th

90th

Males and Females

Total, 3 years and older

1.77

(1.51-2.08)

< LOD

1.60

(1.30-1.90)

6.10

(4.80-8.20)

1992

3–5 years

1.75

(1.40-2.17)

< LOD

1.40

(1.10-1.80)

5.00

(3.20-13.9)

128

6–11 years

1.92

(1.69-2.19)

.900

(.800-1.00)

1.70

(1.40-1.90)

4.30

(3.50-5.60)

340

12–19 years

1.38

(1.20-1.59)

< LOD

1.20

(1.10-1.50)

3.90

(2.80-5.30)

671

20–39 years

1.71

(1.27-2.29)

< LOD

1.50

(1.10-2.10)

5.80

(3.90-11.4)

319

40–59 years

1.88

(1.65-2.13)

< LOD

1.80

(1.50-2.00)

7.20

(6.10-9.70)

291

60 years and older

2.22

(1.70-2.90)

< LOD

2.00

(1.40-2.70)

9.30

(4.90-15.1)

243

Males

Total, 3 years and older

1.65

(1.38-1.96)

< LOD

1.40

(1.20-1.80)

5.80

(4.20-7.40)

984

3–5 years

1.54

(1.18-2.02)

< LOD†

1.30

(1.00-1.90)

3.90†

(2.20-13.9)

64

6–11 years

2.08

(1.82-2.36)

.900

(.800-1.20)

1.90

(1.70-2.20)

4.60

(3.50-6.60)

175

12–19 years

1.32

(1.11-1.57)

< LOD

1.10

(1.00-1.34)

3.30

(2.70-5.50)

340

20–39 years

1.55

(1.07-2.24)

< LOD

1.40

(.900-2.30)

6.10

(3.40-9.60)

132

40–59 years

1.71

(1.44-2.03)

< LOD

1.80

(1.20-2.10)

6.60

(4.50-8.40)

154

60 years and older

1.94

(1.56-2.43)

< LOD

1.50

(1.30-2.40)

6.70

(4.20-12.5)

119

Females

Total, 3 years and older

1.88

(1.58-2.23)

< LOD

1.70

(1.40-1.90)

6.50

(4.90-9.40)

1008

3–5 years

1.98

(1.52-2.60)

< LOD†

1.70

(1.30-2.20)

6.00†

(3.20-33.8)

64

6–11 years

1.76

(1.40-2.22)

.700

(<LOD-.900)

1.60

(1.30-1.90)

3.70

(2.60-8.30)

165

12–19 years

1.45

(1.27-1.65)

< LOD

1.30

(1.10-1.60)

4.00

(2.90-5.50)

331

20–39 years

1.83

(1.33-2.50)

< LOD

1.80

(1.10-2.20)

5.30

(3.90-11.5)

187

40–59 years

2.04

(1.69-2.46)

< LOD

1.70

(1.50-2.10)

7.90

(5.90-13.8)

137

60 years and older

2.44

(1.71-3.47)

< LOD

2.10

(1.40-3.20)

9.40

(5.90-17.6)

124

< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.

Table 2.4.d. Serum alpha-carotene: Non-Hispanic whites

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the U.S.population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean(95% conf. interval)

Selected percentiles (95% conf. interval)

Samplesize

10th

50th

90th

Males and Females

Total, 3 years and older

2.57

(2.25-2.94)

.800

(<LOD-.900)

2.40

(2.10-2.90)

8.80

(7.70-10.2)

3583

3–5 years

2.46

(1.95-3.11)

.800

(<LOD-1.40)

2.10

(1.70-3.00)

8.50

(5.60-11.1)

133

6–11 years

2.29

(1.98-2.65)

.700

(<LOD-.900)

2.20

(1.80-2.50)

6.50

(4.90-10.2)

301

12–19 years

1.69

(1.48-1.93)

< LOD

1.40

(1.20-1.70)

5.30

(4.40-6.50)

656

20–39 years

2.17

(1.86-2.55)

< LOD

2.00

(1.60-2.30)

8.10

(6.30-9.20)

772

40–59 years

3.12

(2.66-3.67)

.900

(.800-1.20)

2.90

(2.50-3.40)

11.3

(8.60-14.2)

777

60 years and older

3.16

(2.78-3.58)

.900

(<LOD-1.00)

3.30

(2.80-3.80)

9.20

(8.50-9.90)

944

Males

Total, 3 years and older

2.28

(1.99-2.62)

< LOD

2.10

(1.90-2.60)

7.80

(6.30-9.20)

1739

3–5 years

2.44

(1.99-2.98)

1.00†

(<LOD-1.30)

2.20

(1.70-2.50)

8.50†

(4.40-11.3)

72

6–11 years

2.35

(1.87-2.96)

.900

(<LOD-1.10)

2.00

(1.60-2.70)

8.10

(4.40-13.4)

157

12–19 years

1.53

(1.31-1.79)

< LOD

1.30

(1.10-1.70)

4.40

(3.80-6.20)

323

20–39 years

1.95

(1.66-2.28)

< LOD

1.90

(1.50-2.10)

7.30

(5.20-8.90)

312

40–59 years

2.59

(2.16-3.11)

.800

(<LOD-.900)

2.50

(2.00-3.00)

8.80

(5.70-12.0)

407

60 years and older

2.86

(2.47-3.32)

.800

(<LOD-.900)

3.00

(2.30-3.70)

8.40

(7.40-9.80)

468

Females

Total, 3 years and older

2.89

(2.49-3.35)

.700

(<LOD-.900)

2.90

(2.40-3.20)

9.70

(8.30-11.5)

1844

3–5 years

2.49

(1.49-4.17)

< LOD†

2.20

(1.50-4.70)

8.50†

(5.40-14.7)

61

6–11 years

2.22

(1.97-2.50)

.700

(<LOD-.900)

2.20

(1.80-2.60)

6.00

(4.40-8.40)

144

12–19 years

1.86

(1.58-2.19)

< LOD

1.70

(1.50-2.20)

5.90

(4.80-7.50)

333

20–39 years

2.40

(2.00-2.89)

< LOD

2.30

(1.80-2.80)

8.30

(7.20-10.5)

460

40–59 years

3.83

(3.26-4.51)

1.20

(.900-1.40)

3.60

(3.10-4.50)

12.7

(10.4-17.0)

370

60 years and older

3.40

(2.92-3.96)

1.10

(.800-1.30)

3.37

(2.90-4.10)

9.50

(8.60-10.5)

476

< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.